Eli Lilly (LLY) recently entered a collaboration with Gate Bioscience to develop molecular gate therapeutics, a move that ...

Eli Lilly and Co : Jaypirca de Lilly, le premier et unique inhibiteur de BTK non covalent approuvé, a atteint son critère ...

Eli Lilly is walking through the Gate, inking a deal worth up to $856 million with a biotech aiming to build out a new ...

Collaboration combines Gate Bioscience's Molecular Gate drug discovery engine with Lilly's expertise in small molecule therapeutics. Company to receive an upfront payment, an equity investment, ...

Gate Bioscience Inc. has entered a collaboration and license agreement with Eli Lilly and Co. to discover, develop and ...

BMO Capital est positif et recommande le titre à l'achat. Pas de modification majeure pour l'objectif de cours qui passe de 900 à 920 USD.

Eli Lilly (LLY) recently received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for its ...

En comparant Eli Lilly et Novo Nordisk, c’est la pharmaceutique américaine qui séduit davantage Shady Aboul-Enein, maître d’enseignement à HEC Montréal, notamment pour ses états ...